Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.63
-3.01 (-1.43%)
AAPL  272.55
-1.68 (-0.61%)
AMD  203.36
-7.50 (-3.56%)
BAC  52.40
+0.71 (1.37%)
GOOG  307.54
-5.49 (-1.75%)
META  657.91
+4.22 (0.65%)
MSFT  401.50
+0.90 (0.22%)
NVDA  184.84
-10.72 (-5.48%)
ORCL  149.71
+1.82 (1.23%)
TSLA  408.66
-8.74 (-2.09%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.